Abstract
Although a role for growth factors in angiogenesis was first recognized in 1971 an explosion in growth factor identification and characterization has occurred over the last 5 years. Widespread use of recombinant DNA technology has led to the identification of new peptide growth factors (and in many cases their receptors) which are capable of stimulating angiogenesis. For example, the family of Heparin Binding Growth Factors (HBGF’s), which includes Fibroblast Growth Factor (FGF), has had five new members identified since 1987, bringing the total in 1992 to seven. There are currently four receptors for the HBGF family which have been identified and partially characterized. Despite cloning and in vitro characterization of growth factors, their contribution to developmental, physiologic or pathologic angiogenesis remains largely speculative [1]. Growth factors are considered angiogenic on the basis of in vitro or biologic assays, but the in vivo activity of any particular growth factor appears to be contextual, i.e. modulated by the presence of other growth factors, as well as the extracellular milieu and participating cell types [2]. Angiogenesis is a complex process shaped by the interplay of stimulatory and inhibitory factors, the choreography of which is an important subject for angiogenesis research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Folkman J, Klagsbrun M. Angiogenic Factors. Science 1987; 235: 442–447.
Sporn M, Roberts A. Autocrine growth factors and cancer. Nature 1985; 313: 745–747.
Schott R, Morrow L. Growth Factors and Angiogenesis. Cardiovascular Research, in press.
Gilbert SF. Developmental Biology. (3rd ed.) Sunderland, MA: Sinauer Associates, 1991: 891.
de Pable F, Roth J. Endocrinization of the early embryo: an emerging role for hormones and hormone-like factors. Trend Biochem Sci 1990; 15: 339–342
Folkman J, Klagsbrun M. A family of angiogenic peptides. Nature 1987; 329: 671–672.
Folkman J, Haudenschild C. Angiogenesis in vitro. Nature 1980; 288: 551–556.
Antonelli-Orlidge A, Smith S, D’Amore P. Influence of pericytes on capillary endothelial cell growth. Annu Rev Respir Dis 1989; 140: 1129–1131.
Schaper W. Angiogenesis in the adult heart. Bas Res Cardiol 1991; 86(suppl 2): 51–56.
Schaper W, Sharma H, Quinkler W, Markert T, Wünsch M, Schaper J. Molecular biologic concepts of coronary anastomoses. J Am Coll Cardiol 1990; 15: 513–8.
Sasayama S, Fujita M. Recent insights into coronary collateral circulation. Circulation 1992; 85: 1197–1204
Barger A, Beeuwkes R, Lainey L, Silverman K. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. N Engl J Med 1984; 310: 175–177.
Eisenstein R. Angiogenesis in arteries: review. Pharmac Ther 1991; 49: 1–19.
Tomanek R. Response of the coronary vasculature to myocardial hypertrophy. J Am Coll Cardiol 1990; 15: 528–533.
Flanagan M, Fujii A, Colan S, Flanagan R, Lock J. Myocardial angiogenesis and coronary perfusion in left ventricular pressure-overload hypertrophyin the young lamb. Circ Res 1991; 68: 1458–1470.
Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971; 133: 275–288.
Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biologic functions of fibroblast growth factor. Endocrine Rev 1987; 8: 95–114.
Marics I, Adelaide J, Raybaud F, et al. Characterization of the HST-related FGF.6 gene, a new member of the fibroblast growth factor gene family. Oncogene 1989; 4: 335–340.
Holtrich U, Bräuninger A, Strebhardt K, Riibsamen-Waigmann H. Two additional protein-tryosine kinases expressed in human lung: fourth member of the fibroblast growth factor receptor family and an intracellular protein-tyrosine kinase. Proc Natl Acad Sci USA 1991; 88: 10411–10415.
Schmidt M, Sharma HS, Schott, RJ, Schaper, W. Amplification and sequencing of mRNA encoding acidic fibroblast growth factor aFGF from porcine heart. Biochem Biophys Res Comm 1991; 180: 853–859.
Conn G, Bayne M, Soderman D, et al. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 1990; 87: 2628–2632.
Lee P, Johnson D, Cousens L, Fried V, Williams L. Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science 1989; 245: 57–60.
Burgess W, Shaheen A, Ravera M, Jaye M, Donohue P, Winkles J. Possible dissociation of the heparin-binding and mitogenic activities of Heparin-binding (Acidic Fibroblast) Growth Factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue. J Cell Biol 1990; 111: 2129–2138.
Daopin S, Piez K, Ogawa Y, Davies D. Crystal structure Transforming Growth Factor-ß2: an unusual fold for the superfamily. Science 1992; 257: 369–373
Auerbach R, Auerbach W, Polakowski I. Assays for angiogenesis: a review. Pharmac Ther 1991; 51: 1–11.
Thompson J, Anderson K, DiPietro J, et al. Site-directed neovessel formation in vivo. Science 1988; 241: 1349–1352.
Banai S, Jaklitsch MT, Casscells W, Shou M, Shrivastav S, Correa R, Epstein SE, Unger EF. Effects of acidic fibroblast growth factor on normal and ischemie myocardium. Circ Research 1991; 69(1): 76–85.
Gospodarowicz D, Neufeld G, Schweigerer L. Fibroblast growth factor. Mol Cell Endocrinol 1986; 46: 187–204.
Yoshida T, Miyagawa K, Odagiri H, et al. Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein. Proc Natl Acad Sci USA 1987; 84: 7305–7309.
Moore R, Casey G, Brookes S, Dixon M, Peters G, Dickson C. Sequence, topography and protein coding potential of mouse int-2: a putative oncogene activated by mouse mammary tumour virus. EMBO 1986; 5: 919–924.
Zhan X, Bates B, Hu X, Goldfarb M. The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors. Mol Cell Biol 1988; 8: 3487–3495.
Delli Bovi P, Curatola A, Kern F, Greco A, Ittmann M, Basilico C. An oncogene isolated by transfection of Kaposi’s sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 1987; 50: 729–737.
Esch F, Baird A, Ling N, et al. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci USA 1985; 82: 6507–6511.
Johnson D, Lee P, Lu J, Williams L. Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol Cell Biol 1990; 10: 4728–4736.
Keegan K, Johnson D, Williams L, Hayman M. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci USA 1991; 88: 1095–1099.
Yayon A, Klagsbrun M, Esko J, Leder P, Ornitz D. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841–848.
Unger E, Sheffield C, Epstein SE. Creation of an anastomoses betweenan extracardiac artery and the coronary circulation. Circulation. 1990; 82: 1449–1466.
Vlodavsky I, Folkman J, Sullivan R, et al. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 1987; 84: 2292–2296.
Winkles J, Friesel R, Burgess W, et al. Human vascular smooth muscle cell both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Proc Natl Acad Sci USA 1987; 84: 7124–7128.
Quinkler W, Maasberg M, Bernotat-Danielowski S, Lüthe N, Sharma H, Schaper W. Isolation of heparin binding growth factors from bovine, porcine, and canine hearts. Eur J Biochem 1989; 181: 67–73.
Casscells W, Speir E, Sasse J, et al. Isolation, characterization, and localization of heparin-binding growth factors in the heart. J Clin Invest 1990; 85: 433–441.
Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I. A heparin-binding angiogenic protein — basic fibroblast growth factor — is stored within basement membrane. Am J Pathol 1988; 130: 393–400.
Baird A, Ling N. Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochem Biophy Res Comm 1987; 142: 428–435.
Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64: 867–869.
Mignatti P, Morimoto T, Rifkin D. Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc Natl Acad Sci USA 1991; 88: 11007–11011.
Slack J, Darlington B, Heath J, Godsave S. Mesoderm induction in early Xenopus embryos by heparin-binding growth factors. Nature 1987; 326: 197–200.
Kimelman D, Kirschner M. Synergistic induction of mesoderm by FGF and TGF-ß and the identification of an mRNA coding for FGF in the early Xenopus embryo. Cell 1987; 51: 869–877.
Rogelj S, Weinberg R, Fanning P, Klagsbrun M. Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature 1988; 331: 173–175.
Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 1991; 66: 1095–1104.
Montesano R, Vassalli J-D, Baird A, Guillemin R, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 1986; 83: 7297–7301.
Thomas K, Rios-Candelore M, Gimenez-Gallego, et al. Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proc Natl Acad Sci USA 1985; 82: 6409–6413.
Gross J, Moscatelli D, Rifkin D. Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro. Proc Natl Acad Sci USA 1983; 80: 2623–2627.
Saksela O, Moscatelli D, Rifkin D. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol 1987; 105: 957–963.
Folkman J, Weisz P, Joullié M, Li W, Ewing W. Control of angiogenesis with synthetic heparin substitutes. Science 1989; 243: 1490–1493.
Anzano M, Roberts A, Smith J, Sporn M, DeLarco J. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. Proc Natl Acad Sci USA 1983; 80: 6264–6268.
Derynck R, Jarrett J, Chen E, et al. Human transforming growth factor-ß complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 316: 701–705.
Roberts A, Kim S, Noma T, et al. Multiple forms of TGF-beta: distinct promoters and differential expression. Ciba Found Symp 1991; 157: 7–15.
Sporn M, Roberts A, Wakefield L, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 1987; 105: 1039–1045.
Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF. Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992;68:775–785.
López-Cassillas F, Cheifetz S, Doody J, Andres J, Lane W, Massaguó J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-ß receptor system. Cell 1991; 67: 785–795.
Wang X-F, Lin H, Ng-Eaton E, Downward J, Lodish H, Weinberg R. Expression cloning and characterization of the TGF-ß type III receptor. Cell 1991; 67: 797–805.
Miyazono K, Heldin C. Latent forms of TGF-beta: molecular structure and mechanisms of activation. Ciba Found Symp 1991; 157: 81–89.
Dennis PA, Rifkin DB. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose beta-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 1991; 88: 580–584.
Gaffen JD. Interaction between the cell surface and the extracellular matrix. Br J Rheum 1992; 31: 74–76.
Wakefield L, Smith D, Masui T, Harris C, Sporn M. Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol 1987; 105: 965–975.
Boyd F, Cheifetz S, Andres J, Laiho M, Massaguó J. Transforming growth factor-beta receptors and binding proteoglycans. J Cell Sci(suppl) 1990; 13: 131–138.
Eghbali M, Tomek R, Woods C, Bhambi B. Cardiac fibroblasts are predisposed to convert into myocyte phenotype: specific effect of transforming growth factor ß. Proc Natl Acad Sci USA 1991; 88: 795–799.
Lynch S, Colvin R, Antoniades H. Growth factors in wound healing. J Clin Invest 1989; 84: 640–646.
Heimark R, Twardzik D, Schwartz S. Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 1986; 233: 1078–1080.
Kehrl J. Transforming growth factor-beta: an important mediator of immunoregulation. Int J Cell Cloning 1991; 9: 438–50.
Roberts A, Sporn M, Assoian R, et al. Transforming growth factor type ß: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986; 83: 4167–171.
Wiseman D, Polverini P, Kamp D, Leibovich S. Transforming growth factor-beta (TGFß) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Comm 1988; 157: 793–800.
McCartney F, Mizel D, Wong H, Wahl L, Wahl S. TGF-beta regulates production of growth factors and TGF-beta by human peripheral blood monocytes. Growth Factors 1990;4:27–35.
Pepper M, Belin D, Montesano R, Orci L, Vassalli J-D. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 1990; 111: 743–755.
Rifkin D, Moscatelli D, Bizik J, et al. Growth factor control of extracellular proteolysis. Cell Differ Dev 1990; 323: 313–318.
Ignotz R, Massagué J. Transforming growth factor-ß stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337–345.
Madri J, Pratt B, Tucker A. Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol 1988; 10: 1375–1384.
Carpenter G, Cohen S. Epidermal growth factor. J Biol Chem 1990; 265: 7709–7712.
Carpenter G, Wahl M. The epidermal growth factor family. In: Sporn MB Roberts A, ed. Peptide Growth Factors and Their Receptors I. 1 ed. Berlin: Springer-Verlag, 1990: 69–171. vol 95
Schreiber A, Winkler M, Derynck R. Transforming growth factor-a: a more potent angiogenic mediator than epidermal growth factor. Science 1986; 232: 1250–1252.
Ross R. The pathogenesis of atherosclerosis — an update. N Engl J Med 1986; 314: 488–500.
Sato N, Nariuchi H, Tsuruoka N, et al. Actions of TNF and IFN-γ on angiogenesis in vitro. J Invest Dermatol 1990; 95: 85S–89S.
Heldin C-H, Westermark B. Platelet-derived growth factor: three isoforms and two receptor types. Trends Genet 1989; 5: 108–111.
Gospodarowicz D, Abraham J, Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 1989; 86: 7311–7315.
Tischer E, Gospodarowicz D, Mitchell R, et al. Vascular endothelial growth factor: an new member of the platelet-derived growth factor gene family. Biochem Biophys Res Comm 1989; 165: 1198–1206.
Leung D, Cachianes G, Kuang W-J, Goeddel D, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306–1309.
Keck P, Hauser S, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246: 1309–1312.
Conn G, Soderman D, Schaeffer M-T, Wile M, Hatcher V, Thomas K. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 1990; 87: 1323–1327.
Berse B, Brown L, Sioussat T, Senger D, Dvorak H. Vascular permeability factor (vascular endothelial growth factor) expression in normal tissues and in tumors. J Cell Biol 1991; 115(3 Part 2): 2443, abstract.
Connolly D, Heuvelman DM, Nelson R et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470–1478.
Vaisman N, Gospodarowicz D, Neufeld G. Characterization of the receptors for vascular endothelial growth factor. J Biol Chem 1990; 265: 19461–19466.
Jakeman LB, Winer J, Bennett GL, Altar CA, Ferrara. Binding sites for Vascular Endothelial Growth Factor are localized on endothelial cells in adult rat tissues. J Clin Invest 1992; 89: 244–53
De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fins-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989–991
Koos R, Olson C. Hypoxia stimulates expression of the gene for vascular endothelial growth factor (VEGF), a putative angiogenic factor, by granulosa cells of the ovarian follicle, a site of angiogenesis. J Cell Biol 1991; 115(3 Part 2): 2444.
Gitay-Goren H, Soker S, Vlodavsky I, Neufeld G. The binding of Vascular Endothelial Growth Factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem. 1992; 267(9): 6093–6098.
Fett J, Strydom D, Lobb R, et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochem 1985; 24: 5480–5486.
Strydom D, Fett J, Lobb R, et al. Amino acid sequence of human tumor derived angiogenin. Biochem 1985; 24: 5486–5494.
Kurachi K, Davie E, Strydom D, Riordan J, Vallee B. Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor. Biochem 1985; 24: 5494–5499.
Weiner H, Weiner L, Swain J. Tissue distribution and developmental expression of the messenger RNA encoding angiogenin. Science 1987; 237: 280–282.
Hu G-F, Chang S-I, Riordan J, Vallee B. An angiogenin-binding protein from endothelial cells. Proc Natl Acad Sci USA 1991; 88: 2227–2231.
Höckel M, Sasse J, Wissler J. Purified monocyte-derived angiogenic substance (angiotropin) stimulates migration, phenotypic changes, and ″tube formation″ but not proliferation of capillary endothelial cells in vitro. J Cell Physiol 1987; 133: 1–13.
Miyazono K, Okabe T, Urabe A, Takaku F, Heldin C-H. Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 1987; 262: 4098–4103.
Ishikawa F, Miyazono K, Hellman U, et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989; 338: 557–562.
Usuki K, Heldin N-E, Miyazono K, et al. Production of platelet-derived endothelial cell growth factor by normal and transformed human cells in culture. Proc Natl Acad Sci USA 1989; 86: 7427–7431.
Fràter-Schròder M, Risau W, Hallmann R, Gautschi P, Böhlen P. Tumor necrosis factor type a, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 1987; 84: 5277–5281.
Knighton D, Hunt T, Scheuenstuhl H, Halliday B. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 1983; 221: 1283–1285.
Leibovich S, Polverini P, Shepard H, Wiseman D, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumor necrosis factor-alpha. Nature 1987; 329: 630–632.
Klagsbrun M, D’Amore P. Regulators of angiogenesis. Annu Rev Physiol 1991; 53: 217–239.
Odedra R, Weiss J. Low molecular weight angiogenesis factors. PharmacTher 1991; 49: 111–124.
Kull F, Brent K, Parikh I, Cuatrecasas P. Chemical identification of a tumor-derived angiogenic factor. Science 1987; 236: 843–845.
Morris P, Ellis M, Swain J. Angiogenic potency of nucleotide metabolites: potential role in ischemia-induced vascular growth. J Mol Cell Cardiol 1989; 21: 351–358.
Dusseau J, Hutchins P, Malbasa D. Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane. Circ Res 1986; 59:163–170.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schott, R.J., Morrow, L.A. (1993). The role of growth factors in angiogenesis. In: Cummins, P. (eds) Growth Factors and the Cardiovascular System. Developments in Cardiovascular Medicine, vol 147. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3098-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3098-5_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6354-5
Online ISBN: 978-1-4615-3098-5
eBook Packages: Springer Book Archive